Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Total Current Liabilities: 2023-2024

Historic Total Current Liabilities for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $10.7 million.

  • Upstream Bio's Total Current Liabilities rose 9.51% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year increase of 9.51%. This contributed to the annual value of $10.7 million for FY2024, which is 64.80% up from last year.
  • According to the latest figures from FY2024, Upstream Bio's Total Current Liabilities is $10.7 million, which was up 64.80% from $6.5 million recorded in FY2023.
  • Upstream Bio's Total Current Liabilities' 5-year high stood at $10.7 million during FY2024, with a 5-year trough of $6.5 million in FY2023.
  • For the 2-year period, Upstream Bio's Total Current Liabilities averaged around $8.6 million, with its median value being $8.6 million (2023).
  • Data for Upstream Bio's Total Current Liabilities shows a peak YoY skyrocketed of 64.80% (in 2024) over the last 5 years.
  • Upstream Bio's Total Current Liabilities (Yearly) stood at $6.5 million in 2023, then spiked by 64.80% to $10.7 million in 2024.